Skip to content

Clinical trials

Terminated Phase 2/3 trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Terminated Country / region: Canada Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20041
20052
20066
20074
20088
20094
20101
20113
20123
20134
20146
20157
20163
20177
20182
20197
202010
20214
20227
20234
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated100

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto4
University of Alberta3
AstraZeneca2
Boehringer Ingelheim2
Bristol-Myers Squibb2
Eli Lilly and Company2
Facet Biotech2
Gilead Sciences2
Janssen Research & Development, LLC2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-196
Colitis, Ulcerative6
Alzheimer Disease5
Inflammatory Bowel Diseases4
Breast Neoplasms3
Crohn Disease3
Dementia3
Heart Failure3
Amyotrophic Lateral Sclerosis2
Clostridium Infections2

Trials

Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.